Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Natasha C H Ting"'
Autor:
Nicole El-Turk, Michael S H Chou, Natasha C H Ting, Afaf Girgis, Shalini K Vinod, Victoria Bray, Claudia C Dobler
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245492 (2021)
IntroductionPatients' burden from lung cancer treatment is not well researched, but this understanding can facilitate a patient-centred treatment approach. Current models of treatment burden suggest it is influenced by a patient's perception of their
Externí odkaz:
https://doaj.org/article/86416b686bdf40aeafdfd1027bbba2d9
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252915 (2021)
BackgroundLittle is known about the treatment burden experienced by patients with obstructive sleep apnoea (OSA) who use continuous positive airway pressure (CPAP) therapy.Participants18 patients (33.3% males, mean age 59.7±11.8 years) with OSA who
Externí odkaz:
https://doaj.org/article/e5ec08f814434093b91bc9aaeb630d60
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241124 (2020)
BackgroundTreatment for tuberculosis lasts for a minimum of 6 months. The treatment burden experienced by patients in a low-incidence setting where directly observed therapy is the standard of care is not well-known.MethodsPatients receiving tubercul
Externí odkaz:
https://doaj.org/article/5e6360d9376b4dd4956c391421697859
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0252915 (2021)
PLoS ONE, Vol 16, Iss 6, p e0252915 (2021)
Background Little is known about the treatment burden experienced by patients with obstructive sleep apnoea (OSA) who use continuous positive airway pressure (CPAP) therapy. Participants 18 patients (33.3% males, mean age 59.7±11.8 years) with OSA w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1105b9650df2786feb81e06643ec2d
http://europepmc.org/articles/PMC8183990
http://europepmc.org/articles/PMC8183990
Autor:
Afaf Girgis, Victoria J Bray, Shalini K Vinod, Natasha C H Ting, Michael S H Chou, Claudia C. Dobler, Nicole El-Turk
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 1, p e0245492 (2021)
PLoS ONE, Vol 16, Iss 1, p e0245492 (2021)
Introduction Patients’ burden from lung cancer treatment is not well researched, but this understanding can facilitate a patient-centred treatment approach. Current models of treatment burden suggest it is influenced by a patient’s perception of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3053047b256d62f9102c6d6a08682275
https://doi.org/10.1371/journal.pone.0245492
https://doi.org/10.1371/journal.pone.0245492
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241124 (2020)
PLoS ONE
PLoS ONE
BackgroundTreatment for tuberculosis lasts for a minimum of 6 months. The treatment burden experienced by patients in a low-incidence setting where directly observed therapy is the standard of care is not well-known.MethodsPatients receiving tubercul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f8c0aa4c359fb2b16ed8a178ea63f8
https://doi.org/10.1371/journal.pone.0241124
https://doi.org/10.1371/journal.pone.0241124